Prospective study of catalase-positive coryneform organisms in clinical specimens: Identification, clinical relevance, and antibiotic susceptibility

Diagnostic Microbiology and Infectious Disease

Volumn 30, Issue 1, 1998, Pages 7-15

  Lagrou, K ^a   Verhaegen, J ^a   Janssens, M ^b   Wauters, G ^b   Verbist, L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIAMINO 6,7 DIISOPROPYLPTERIDINE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; OFLOXACIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ACTINOMYCETALES; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM; CORYNEBACTERIUM UREALYTICUM; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ACTINOMYCETALES; ANTI-BACTERIAL AGENTS; BELGIUM; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES;

EID: 0031893345     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00193-4     Document Type: Article

References (32)

1. Barbut FA, Petit JC. Infections à Corynebacterium jeikeium épidémiologie, clinique, diagnostic et traitement . Lett Infectiol. 13:1995;501-506.
2. Bernard KA, et al. Cellular fatty acid composition as an adjunct to the identification of asporogenous, aerobic gram-positive rods. J Clin Microbiol. 29:1991;83-89.
3. Clarridge JE, Spiegel CA. Corynebacterium and miscellaneous irregular gram-positive rods, Erysipelothrix, and Gardnerella. Murray PR, Baron EJ, Pfaller MA, Tenover FG, Yolken RH. Manual of Clinical Microbiology. 1995;357-378 American Society for Microbiology, Washington DC.
4. Collins MD, et al. Corynebacterium amycolatum sp. nov. a new mycolic acid-less Corynebacterium species from human skin. FEBS Microbiol Lett. 49:1988;349-352.
5. Coyle MB, Lipsky BA. Coryneform bacteria in infectious diseases clinical and laboratory aspects . Clin Microbiol Rev. 3:1990;227-246.
6. Funke G, et al. Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum. J Clin Microbiol. 34:1996;1124-1128.
7. Funke G, et al. Corynebacterium glucuronolyticum sp. nov. isolated from male patients with genitourinary infections. Med Microbiol Lett. 4:1995;204-215.
8. Funke G, et al. Heterogeneity within human-derived Centers for Disease Control and Prevention (CDC) coryneform group ANF-1-like bacteria and description of Corynebacterium auris sp. nov. Int J Syst Bacteriol. 45:1995;735-739.
9. Funke G, et al. Characteristics of CDC group 3 and group 5 coryneform bacteria isolated from clinical specimens and assignment to the genus Dermabacter. J Clin Microbiol. 32:1994;1223-1228.
10. Funke G, et al. Primary identification of Aureobacterium spp. isolated from clinical specimens as "Corynebacterium aquaticum" J Clin Microbiol. 32:1994;2686-2691.
11. Funke G, et al. Primary identification of Microbacterium spp. encountered in clinical specimens as CDC coryneform group A-4 and A-5 bacteria. J Clin Microbiol. 33:1995;188-192.
12. Funke G, et al. Identification of some clinical strains of CDC coryneform group A-3 and A-4 bacteria as Cellulomonas species and proposal of Cellulomonas hominis sp. nov. for some group A-3 strains. J Clin Microbiol. 33:1995;2091-2097.
13. Funke G, et al. Clinical microbiology of coryneform bacteria. Clin Microbiol Rev. 10:1997;125-159.
14. Gruner E, et al. Human infections caused by Brevibacterium casei formerly CDC groups B-1 and B-3. J Clin Microbiol. 32:1994;1511-1518.
15. Hollis DG, Weaver RE. Guide for Identification of Coryneform Bacteria. 1981;Centers for Disease Control, Atlanta.
16. Lambert MA, Moss CW. Cellular fatty acid compositions and isoprenoid quinone contents of 23 Legionella species. J Clin Microbiol. 27:1989;465-473.
17. Marinez-Martinez L, et al. Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples. J Clin Microbiol. 33:1995;2458-2461.
18. Nash P, Krenz MM. Culture media. Ballows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ. Manual of Clinical Microbiology. 1991;1226-1288 American Society for Microbiology, Washington DC.
19. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS document M100-S6. 1995;National Committee for Clinical Laboratory Standards, Villanova, PA.
20. Riegel P, et al. Taxonomic study of Corynebacterium group ANF-1 strains: proposal of Corynebacterium afermentans sp. nov. containing the subspecies C. afermentans subsp. afermentans subsp. nov. and C. afermentans subsp. lipophilum subsp. nov. Int J Syst Bacteriol. 43:1993;287-292.
21. Riegel P, et al. Corynebacterium seminale sp. nov., a new species associated with genital infections in male patients. J Clin Microbiol. 33:1995;2244-2249.
22. Riegel P, et al. Corynebacterium argentoratense sp. nov. from the human throat. Int J Syst Bacteriol. 45:1995;533-537.
23. Riegel P, et al. Genomic diversity and phylogenetic relationship among lipid-requiring diphtheroids from humans and characterisation of Corynebacterium macginleyi sp. nov. Int J Syst Bacteriol. 45:1995;128-133.
24. Riegel P, et al. Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources. Eur J Clin Microbiol Infect Dis. 15:1996;657-662.
25. Sierra G. A simple method for detection of lipolytic activity of microorganisms and some observations on the influence of the contact between cells and fatty substrates. Antonie van Leeuwenhoek J Microbiol Serol. 23:1957;15-22.
26. Soriano F, et al. Non-urinary tract infections caused by multiply antibiotic-resistant Corynebacterium urealyticum. Clin Infect Dis. 17:1993;890-891.
27. Soriano F, et al. Antimicrobial susceptibilities of Corynebacterium species and other non-spore forming Gram-positive bacilli of 18 antimicrobial agents. Antimicrob Agents Chemother. 39:1995;208-214.
28. Von Graevenitz A, et al. Grouping of some clinically relevant Gram-positive rods by automated fatty acid analysis. Diagn Implications APMIS. 99:1991;147-154.
29. 2 coryneforms belong to the species Corynebacterium amycolatum. Int J Syst Bacteriol. 46:1996;648-652.
30. Weiss K, et al. Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods. Antimicrob Agents Chemother. 40:1996;930-933.
31. Williams DY, et al. Identification of clinical isolates of nondiphtherial Corynebacterium species and their antibiotic susceptibility patterns. Diagn Microbiol Infect Dis. 17:1993;23-28.
32. Zapardiel J, et al. Problems in minimum inhibitory concentration determinations in coryneforms organisms. Comparison of an agar dilution and the E-test. Diagn Microbiol Infect Dis. 19:1994;171-173.